Philadelphia partner Kathryn Doyle will present on a panel discussing what every investigator should know about intellectual property in biotechnology startup companies. In addition to discussing issues specific to investigators, entrepreneurs and investors, the session will cover the prevailing treatment of the U.S. Patent and Trade Office and the courts regarding gene sequencing, doctrine of equivalents and international issues. Kathryn will also review intellectual property concerns of licensor and licensee.